{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:29:22Z","timestamp":1790976562712,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007963","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000}}],"reference-count":66,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007963.pub2","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T17:21:04Z","timestamp":1364577664000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Oxcarbazepine for neuropathic pain"],"prefix":"10.1002","author":[{"given":"Muke","family":"Zhou","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, Sichuan University; Epidemic Disease & Health Statistics Department; Sichuan Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbo","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Pharmacy; No.37, Guo Xue Xiang Chengdu Sichuan China 60041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD007963.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0002|cit2","first-page":"101","article-title":"Results of a randomized, placebo-controlled trial suggest oxcarbazepine has a therapeutic effect in the treatment of painful diabetic neuropathy","volume":"11 Suppl 2","author":"Beydoun","year":"2004","journal-title":"European Journal of Neurology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD007963.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jpain.2004.02.560","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"5","author":"Dogra","year":"2004","journal-title":"Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub2-BIB0005|cit4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"9","author":"Dogra","year":"2005","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0004|cit5","first-page":"92","article-title":"Oxcarbazepine provides pain relief in patients with painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"11 Suppl 2","author":"Dogra","year":"2004","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0404.2005.00559.x","article-title":"A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy","volume":"114","author":"Grosskopf","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0007|cit7","first-page":"101","article-title":"Oxcarbazepine in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled study","volume":"11 Suppl 2","author":"Riviere","year":"2004","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0009|cit8","unstructured":"Multicenter, double-blind, randomized, placebo-control, parallel-group study to evaluate the safety and efficacy of oxcarbazepine in patients with neuropathic pain due to radiculopathy Novartis Clinical Trials Results Database. http:\/\/www.novartis.com\/innovation\/research-development\/clinical-trials\/index.shtml"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0008|cit9","first-page":"A120","article-title":"Efficacy and safety of oxcarbazepine in patients with neuropathic pain due to radiculopathy: A double-blind, randomized, placebo-controlled study","volume":"64 Suppl 1","author":"Harden","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0010|cit10","first-page":"A471","article-title":"Oxcarbazepine versus carbamazepine in patients with new onset trigeminal neuralgia result of double blind comparative trial [abstract no.P06.116]","volume":"58 Suppl 3","author":"Beydoun","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0404.2006.00710.x","article-title":"Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy","volume":"115","author":"Beydoun","year":"2007","journal-title":"Acta Neurologica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub2-BIB0012|cit12","first-page":"74","article-title":"A randomised controlled trial of 3 drugs for the treatment of idiopathic trigeminal neuralgia","volume":"2","author":"Gong","year":"2010","journal-title":"Journal of China Traditional Chinese Medicine Information"},{"issue":"25","key":"10.1002\/14651858.CD007963.pub2-BIB0013|cit13","first-page":"107","article-title":"The comparative efficacy of oxcarbazepine and carbamazepine for trigeminal neuralgia","volume":"50","author":"Hu","year":"2010","journal-title":"Shandong Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0014|cit14","first-page":"167","article-title":"Clinical efficacy of oxcarbazepine for\u00a0primary trigeminal neuralgia","volume":"21","author":"Li","year":"2011","journal-title":"Zhejiang Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/0304-3959(87)91248-6","article-title":"The analgesic effect of carbamazepine in trigeminal neuralgia","volume":"28 Suppl 4","author":"Lindstr\u00f6m","year":"1987","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1528-1157.1994.tb05946.x","article-title":"Oxcarbazepine and intractable trigeminal neuralgia","volume":"35 Suppl 3","author":"R\u00e9millard","year":"1994","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0017|cit17","first-page":"129","article-title":"Comparison of oxcarbazepine and gabapentin at standard dose in treatment of pain for postherpetic neuropathy","volume":"27","author":"Venancio-Ramirez","year":"2004","journal-title":"Revista Mexicana de Anestesiologia"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0018|cit18","first-page":"89","article-title":"A clinical research on the pharmacological treatment of trigeminal neuralgia","volume":"1","author":"Zhou","year":"2010","journal-title":"Medical Information Operations Sciences Fascicule"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0019|cit19","unstructured":"Brainer-Lima P Naylor F Oxcarbazepine for cancer-related neuropathic pain and opiate detoxification Program and abstracts of the 22nd Annual Meeting of the American Pain Society; March 20-23, 2003; Chicago, Ill 2003"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0020|cit20","first-page":"S5","article-title":"Results of a double-blind trial comparing oxcarbazepine (OXC) vs carbamazepine (CBZ) in newly diagnosed, untreated patients with trigeminal neuralgia","volume":"187 Suppl 1","author":"Liebel","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0021|cit21","unstructured":"NCT01302275 Oxcarbazepine for the treatment of chronic peripheral neuropathic pain (IMIOXC) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01302275"},{"issue":"11","key":"10.1002\/14651858.CD007963.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007963.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1311.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0025|cit25","first-page":"A131","article-title":"Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta-analysis of three double-blind comparative trials","volume":"58 Suppl 3","author":"Beydoun","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0026|cit26","unstructured":"Beydoun A Schmidt D D'souza J on behalf of the oxcarbazepine study group Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia Poster presented at the 21st American Pain Society Annual Meeting Baltimore, USA"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3959(90)90018-9","article-title":"The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation and preliminary investigation for ratio scale properties","volume":"41","author":"Bieri","year":"1990","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009485.pub2","article-title":"Phenytoin for neuropathic pain and fibromyalgia in adults","author":"Birse","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/bjaceaccp\/mkn037","article-title":"Assessment of neuropathic pain","volume":"8","author":"Callin","year":"2008","journal-title":"Continuing Education in Anaesthesia, Critical Care and Pain"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.tpj.6500095","article-title":"Molecular aspects of pain research","volume":"2","author":"Carpenter","year":"2002","journal-title":"The Pharmacogenomics Journal"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD007963.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD007963.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009486.pub2","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults","author":"Corrigan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.2005.00300.x","article-title":"Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin","volume":"111","author":"Criscuolo","year":"2005","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0920-1211(89)90070-3","article-title":"A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy","volume":"3","author":"Dam","year":"1989","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/104990910402100213","article-title":"Epidemiology of cancer pain and factors influencing poor pain control","volume":"21","author":"Davis","year":"2004","journal-title":"American Journal of Hospice and Palliative Care"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/eujp.2001.0323","article-title":"Neurobiology of neuropathic pain: mode of action of anticonvulsants","volume":"6 Suppl A","author":"Dickenson","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0037|cit37","unstructured":"Carbamazepine, oxcarbazepine and eslicarbazepine: potential risk of serious skin reactions associated with the HLA-A* 3101 allele Drug Safety Update 2012 A1"},{"issue":"9","key":"10.1002\/14651858.CD007963.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2165\/00003495-200767090-00003","article-title":"Antiepileptic drugs int the treatment of neuropathic pain","volume":"67","author":"Eisenberg","year":"2007","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1472-8206.2007.00474.x","article-title":"Chronic neuropathic pain: mechanisms, drug targets and measurement","volume":"21","author":"Finnerup","year":"2007","journal-title":"Fundamental Clinical Pharmacology"},{"issue":"13","key":"10.1002\/14651858.CD007963.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe030014","article-title":"Opioids and chronic neuropathic pain","volume":"348","author":"Foley","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007963.pub2-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009183.pub2","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","author":"Gill","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jech.41.3.251","article-title":"Lumbar disc syndrome in Finland","volume":"41","author":"Heliovaara","year":"1987","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0043|cit43","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0044|cit44","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0045|cit45","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009)","author":"Higgins","year":"2009"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0046|cit46","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"1-3","key":"10.1002\/14651858.CD007963.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(01)01302-4","article-title":"The clinical picture of neuropathic pain","volume":"429","author":"Jensen","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6 Suppl A","author":"Jensen","year":"2002","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/0304-3959(87)91248-6","article-title":"The analgesic effect of carbamazepine in trigeminal neuralgia","volume":"30","author":"Lindstrom","year":"1987","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10072-005-0464-z","article-title":"Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies","volume":"26","author":"Magenta","year":"2005","journal-title":"Neurological Sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0051|cit51","volume-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","author":"Merskey","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults.","author":"Moore","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007963.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1517\/13543784.16.10.1615","article-title":"Oxcarbazepine in neuropathic pain","volume":"16","author":"Nasreddine","year":"2007","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD007963.pub2-BIB0056|cit56","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch11","article-title":"Chapter 11: Presenting results and 'Summary of findings' tables","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008)","author":"Sch\u00fcnemann","year":"2008"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tips.2004.10.002","article-title":"Bad news from the brain: descending 5-HT pathways that control spinal pain processing trends","volume":"25","author":"Suzuki","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"issue":"18","key":"10.1002\/14651858.CD007963.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007963.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200519040-00005","article-title":"HIV-associated neuropathic pain: epidemiology, pathophysiology and management","volume":"19","author":"Verma","year":"2005","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1002\/14651858.CD007963.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"12","key":"10.1002\/14651858.CD007963.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.sc.3101641","article-title":"Neuropathic pain after traumatic spinal cord injury? Relations to gender, spinal level, completeness, and age at the time of injury","volume":"42","author":"Werhagen","year":"2004","journal-title":"Spinal Cord"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"WITHDRAWN: Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007963.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub3","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007963.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub2","article-title":"Carbamazepine for acute and chronic pain in adults","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD007963.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2702.2005.01121.x","article-title":"Pain: a review of three commonly used pain rating scales","volume":"14","author":"Williamson","year":"2005","journal-title":"Journal of Clinical Nursing"},{"issue":"3","key":"10.1002\/14651858.CD007963.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007963","article-title":"Oxcarbazepine for neuropathic pain","author":"Zhou","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007963.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T00:00:00Z","timestamp":1512172800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007963.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:15:40Z","timestamp":1628532940000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007963.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":66,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007963.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717995777.793477649","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}